|
ZNF275 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.26350000000131E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.77660000000501E-05 |
| Normal-vs-Stage2 |
2.456600E-01 |
| Normal-vs-Stage3 |
6.91470000035999E-07 |
| Normal-vs-Stage4 |
1.025610E-04 |
| Stage1-vs-Stage2 |
2.054400E-02 |
| Stage1-vs-Stage3 |
2.092200E-01 |
| Stage1-vs-Stage4 |
2.948200E-01 |
| Stage2-vs-Stage3 |
7.619600E-03 |
| Stage2-vs-Stage4 |
8.762500E-03 |
| Stage3-vs-Stage4 |
9.719800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.22540000002669E-06 |
| Normal-vs-AfricanAmerican |
5.481300E-03 |
| Normal-vs-Asian |
3.00730000002414E-06 |
| Caucasian-vs-AfricanAmerican |
9.123800E-01 |
| Caucasian-vs-Asian |
2.196600E-01 |
| AfricanAmerican-vs-Asian |
4.527600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.28669999999165E-06 |
| Normal-vs-Female |
9.421200E-04 |
| Male-vs-Female |
1.993040E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.77280000258318E-08 |
| Normal-vs-Age(41-60Yrs) |
1.499760E-03 |
| Normal-vs-Age(61-80Yrs) |
4.891200E-01 |
| Normal-vs-Age(81-100Yrs) |
9.418100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.406200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.955800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.990800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.230200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.607800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.284300E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.06060000004682E-06 |
| Classical-VS-Follicular |
5.54910000000186E-05 |
| Classical-VS-Other |
5.789200E-01 |
| Classical-VS-Normal |
6.83469999485098E-08 |
| Tall-VS-Follicular |
9.79920034005488E-10 |
| Tall-VS-Other |
2.440200E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
4.994600E-01 |
| Follicular-VS-Normal |
1.515040E-01 |
| Other-VS-Normal |
8.196400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.660950E-01 |
| Normal-vs-N1 |
1.34214861446935E-12 |
| N0-vs-N1 |
2.07230000000003E-05 |
|
|
